While our study did not analyze immune seroconversion in response to mRNA COVID-19 vaccination, we also found increased risk of acquiring SARS-CoV-2 infection in PsD patients treated specifically with the TNF-α inhibitor etanercept. The gene discussed is TNF; the disease is COVID-19.